Open access · US-GOV
via ClinicalTrials.gov Clinical trial
FRAIL and FiND for Assessing Severe Chemotherapy Toxicity Risk in Older Adults With Gastrointestinal Cancer Receiving Adjuvant Chemotherapy
Authors not listed
Ankara Etlik City Hospital · 2025
Abstract
Older adults with gastrointestinal cancer may experience serious side effects during chemotherapy, particularly when they have reduced physical strength, functional limitations, or other health conditions. Identifying patients at greater risk before treatment begins may help clinicians plan appropriate monitoring and supportive care.
The FRAIL-GI study is an observational study evaluating two brief screening tools, the FRAIL scale and the Frail Non-Disabled (FiND) questionnaire, in adults aged 65 years or older receiving adjuvant chemotherapy for nonmetastatic gastrointestinal cancer.
Both tools assess aspects of frailty and physical vulnerability, but they classify patients differently. The FRAIL scale evaluates fatigue, resistance, walking ability, illnesses, and weight loss. The FiND questionnaire assesses frailty-related symptoms while distinguishing patients with mobility disability from those without mobility disability.
The main objective is to investigate whether frailty assessments performed before chemotherapy are associated with severe treatment-related side effects during the following 180 days. Severe toxicity is defined as a grade 3 or higher adverse event according to the Common Terminology Criteria for Adverse Events, version 5.0.
The study also evaluates whether adding FRAIL or FiND information to routine clinical factors improves the identification of patients at increased risk of severe chemotherapy toxicity. Additional assessments examine treatment modifications, unplanned hospitalizations, and the availability of follow-up evaluations.
All chemotherapy regimens and supportive treatments are determined by the treating oncology team according to routine clinical practice. Participation does not involve assignment to an experimental treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-24 MST
Cite this
APA
Anonymous. (2025). FRAIL and FiND for Assessing Severe Chemotherapy Toxicity Risk in Older Adults With Gastrointestinal Cancer Receiving Adjuvant Chemotherapy. <em>Ankara Etlik City Hospital</em>. https://clinicaltrials.gov/study/NCT07272538
Vancouver
Anonymous. FRAIL and FiND for Assessing Severe Chemotherapy Toxicity Risk in Older Adults With Gastrointestinal Cancer Receiving Adjuvant Chemotherapy. Ankara Etlik City Hospital. 2025.
BibTeX
@misc{anon2025FRAILa,
title = {FRAIL and FiND for Assessing Severe Chemotherapy Toxicity Risk in Older Adults With Gastrointestinal Cancer Receiving Adjuvant Chemotherapy},
author = {Anonymous},
journal = {Ankara Etlik City Hospital},
year = {2025},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ju Qiu 2023
Open access · US-GOV
Comparison of Frailty Screening Performance and Predictive Validity of Adverse Health Outcomes in Breast Cancer Patients Using Frailty Screening Tools
Namik Kemal University 2021
Open access · US-GOV
Evaluation of the G8 Questionnaire and the Groningen Frailty Indicator to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 2025
Open access · US-GOV
Effect of a Multicomponent Therapeutic Exercise Program in Primary Care on Frailty and Sarcopenia in Older Adults
New York State Psychiatric Institute 2014
Open access · US-GOV
Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
Our Lady's Hospice and Care Services 2023
Open access · US-GOV
Oral Symptoms in Older Patients With Frailty: a Prospective Observational Study Using the Oral Symptom Assessment Scale
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 2026
Open access · US-GOV